9.62 USD
↗ 0.79 (8.95%)AT CLOSE (11:59 AM EDT)
Artiva Biotherapeutics, Inc. Common Stock
ARTVNASDAQ • USD
9.14
↘ 0.48 (4.98%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
9.14
↘ 0.48 (4.98%)
Market: CLOSED
ARTV is currently priced at $9.62. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, ARTV trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$8.81
High?$9.66
Low?$8.80
Prev. Close?$8.83
Volume?1.0M
Avg. Volume?650.5K
VWAP?$9.23
Rel. Volume?1.60x
Bid / Ask
Bid?$7.86 × 100
Ask?$11.15 × 100
Spread?$3.29
Midpoint?$9.51
Valuation & Ratios
Market Cap?467.4M
Shares Out?24.7M
Float?5.7M
Float %?23.2%
P/E Ratio?N/A
P/B Ratio?5.32
EPS?-$1.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
Themes
Employees
106
Market Cap
429.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-07-19
Address
5505 MOREHOUSE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 267-4467
SAN DIEGO, CA 92121
Phone: (858) 267-4467
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?33
Piotroski F-Score?0/9Weak
Altman Z-Score?8.82Safe
Confidence?41%Low
Short InterestHigh
Short % of Float?18.97%High
Short Interest?1.1M
Days to Cover?1.6
Free Float5.7M
Avg Daily Volume660.7K
Settlement Date2026-06-15
Financial Health
Current Ratio?8.16Strong
Quick Ratio?8.16Strong
Cash Ratio?1.93Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.32FAIR▾
Peers100
S&P35
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-99.1%WEAK▾
S&P3
ROA?-82.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-80178000
Enterprise Value?$446.5M
Fundamentals ratios updated end of day